Loading...
The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects
Abstract Background Fabry disease is a rare inherited glycosphingolipid storage disorder caused by deleterious mutations in the GLA gene coding for the lysosomal enzyme α-galactosidase A. The glucosylceramide synthase inhibitor lucerastat is an iminosugar with potential to provide oral substrate red...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BMC
2020-10-01
|
Serier: | Orphanet Journal of Rare Diseases |
Fag: | |
Online adgang: | http://link.springer.com/article/10.1186/s13023-020-01582-7 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|